#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Matt Holdren Email
VP, Nonclinical Development . Lycia Therapeutics
South San Francisco, CA
LocationPrimary Email
How to contact Matt Holdren
Join and see Matt's contact info for free!Current Roles
Employees:
46Revenue:
$3.6MAbout
We are building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University to develop LYTAC (lysosomal targeting chimera) protein degraders that harness the cell’s lysosomal trafficking and degradation pathway to target both soluble and membrane-bound extracellular proteins. Applications of the LYTAC platform include: targeting challenging membrane proteins, clearing pathogenic immune complexes in circulation and depleting antibodies to specific antigens of interest. The platform can potentially deliver next-generation therapeutics to address a range of difficult-to-treat diseases, including cancer and autoimmune diseases.Lycia Therapeutics Address
681 Gateway BlvdSouth San Francisco, CA